Avoid common mistakes on your manuscript.
Correction to: Quality of Life Research https://doi.org/10.1007/s11136-019-02148-2
The article “Eculizumab improves fatigue in refractory generalized myasthenia gravis”, written by “Henning Andersen, Renato Mantegazza, Jing Jing Wang, Fanny O’Brien, Kaushik Patra, James F. Howard Jr. and The REGAIN Study Group” was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 23 March 2019 without open access.
With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 20 May 2019 to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The original article has been corrected.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Andersen, H., Mantegazza, R., Wang, J.J. et al. Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis. Qual Life Res 28, 2255 (2019). https://doi.org/10.1007/s11136-019-02204-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-019-02204-x